Composition
- Active ingredients
- nogapendekin alfa inbakicept-pmln 400mcg/0.4 mL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761336.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Anktiva
- Active substance
- nogapendekin alfa inbakicept-pmln
- Route
- Into the bladder
- Dosage form
- Solution
- Applicant
- Altor Bioscience, LLC, An Indirect Wholly-Owned Su
- Status
- Prescription
- FDA approval
- 22 Apr 2024
- Application
- BLA761336-001